We quantitatively analyzed RNA-expression from the tumour cells and identified distinct gene expression signatures in the different samples: A9 (metastatic tumours), A9+IL-33 (metastatic), and TC1 (primary tumours) (Fig. 8). This evidence concerns the gene IL33 and metastatic neoplasm.